Hong Kong’s finance chief courted Italian companies on Thursday to go public on the city’s stock exchange, which would allow them to tap into mainland Chinese liquidity and solidify their presence in Asia. Addressing the Trade Development Council’s “Think Business, Think Hong Kong” symposium in Milan, Financial Secretary Paul Chan Mo-po highlighted the deepening ties…
By Charlie Conchie LONDON (Reuters) -AstraZeneca’s move to upgrade its listing in the U.S. risks pulling liquidity away from London’s stock market and could pave the way for other large companies to follow suit, analysts, investors and advisers said. The British drugmaker, one of London’s most valuable listed companies, said on Monday it would retain…
The British government will offer to pay more for medicines that it buys for the National Health Service, the Financial Times reported on Friday, hoping to defuse one of U.S. President Donald Trump’s top complaints after he announced steep tariff increases on branded medication. British Prime Minister Keir Starmer’s chief business adviser, Varun Chandra, will…
We recently published 10 Power Stocks Crushing Wall Street — 7 at All-Time Highs. Mineralys Therapeutics, Inc. (NASDAQ:MLYS) is one of the best performers on Tuesday. Mineralys surged to a new all-time high on Tuesday, as investors gobbled up shares after one of its counterparts posted positive trial results for its aldosterone synthase inhibitor (ASI),…
Those looking to protect themselves against the flu this season now have an at-home option. FluMist, the only nasal spray flu vaccine approved by the Food and Drug Administration, is now available for purchase for self-administration. AstraZeneca’s FluMist was approved in 2003 to be given by health care providers. Last year, the FDA broadened the approval of…
AstraZeneca chief executive Pascal Soriot isn’t confirming or denying reports that the UK’s largest listed company is considering moving its primary stock market listing from London to New York. Yet recent remarks reveal where the company’s future may lie. At AstraZeneca’s half-year results press conference, Soriot gushed about the US, “the country in our industry…
(Reuters) -AstraZeneca CEO Pascal Soriot is considering moving the company’s stock market listing to the U.S., the Times reported on Tuesday, citing multiple sources. Soriot has privately expressed a preference to shift the FTSE 100 company’s listing on multiple occasions and has also discussed relocating AstraZeneca’s domicile, the report said. The company declined to comment…
IonQ recently announced a significant achievement with Kipu Quantum, solving the most complex protein folding problem on a quantum computer. This breakthrough likely contributed to the company’s impressive 87% share price gain last quarter. The successful partnership with AstraZeneca and others to accelerate drug development, and collaborations with Toyota Tsusho and KISTI, bolster its global…